Office for Human Research Protections (OHRP)

Monday, July 30, 2007

8:30 am - 8:45 am

Welcome: Opening remarks
Samuel J. Tilden, M.D.
SACHRP Chair

8:45 am - 9:00 am

Report of Issues/Remarks
Bernard Schwetz, D.V.M., Ph.D.
Director, OHRP

9:00 am - 10:30 am

Report of SIIIDR Subcommittee
David Strauss, M.D.
Laurie Flynn, Co-Chairs

10:30 am -10:45 am

BREAK

10:45 am - 11:30 am

Report of SIIIDR Subcommittee (con't)

11:30 am - 12:30 pm

LUNCH

12:30 pm - 2:30 pm

Report of Subpart A Subcommittee
Felix Gyi, M.B.A., Pharm.D.
Dan Nelson, M.S., CIP
Co-Chairs

2:30 pm - 2:45 pm

BREAK

2:45 pm - 4:00 pm

Subpart A Subcommittee (con't)

4:00 pm - 4:15 pm

Public Comment

4:15 pm - 4:30 pm

Wrap-up discussion and Adjourn

Tuesday, July 31, 2007

8:30 am - 8:45 am

Remarks
Samuel J. Tilden, M.D.
SACHRP Chair

8:45 am - 9:15 am

Briefing on Final Report of National
Conference on IRBs
Bernard Schwetz, Ph.D., D.V.M.,
Director, OHRP

9:15 am - 10:30 am

anel on Informed Consent issues
Howard Dickler, M.D.
   American Association of Medical Colleges
Gigi McMillan
   Executive Director
   WeCan Pediatric Brain Tumor Network
Jonathan Moreno, Ph.D.  
   University of Pennsylvania
Alan R. Fleischman, M.D.
   Ethics Advisor
   The National Children's Study
   NICHD

10:30 am - 10:45 am

BREAK

10:45 am - 11:30 am

Panel on Informed Consent issues

11:30 am - 12:30 pm

LUNCH

12:30 pm - 2:30 pm

Panel on Diversity in
Clinical Trials
Opening Remarks by:
John Agwunobi, M.D.
Assistant Secretary for Health
Introductory Remarks by:
Dorothy Height, Ph.D.
   President Emerita and Chair
   National Council of Negro Women
Panel Moderator:
Giselle Corbie-Smith
   Associate Professor of Social Medicine and Medicine
   University of North Carolina/Chapel Hill
Vivian W. Pinn, M.D.
   Associate Director for Research on Women's Health
   Director, Office of Research on Women's Health
National Institutes of Health
Barbara Pence, M.D.
   Team Leader
   EDICT Project
   Texas Tech University

2:30 pm - 2:45 pm

BREAK

2:45 pm - 4:00 pm

Panel on Diversity in Clinical Trials

4:00 pm - 4: 15 pm

Public Comment

4:15 pm - 4:45 pm

Wrap-up and adjourn